Y-chromosome microdeletions are not associated with SHOX haploinsufficiency. 2013

C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
Andrology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence 50139, Italy.

OBJECTIVE Are Y-chromosome microdeletions associated with SHOX haploinsufficiency, thus representing a risk of skeletal anomalies for the carriers and their male descendents? CONCLUSIONS The present study shows that SHOX haploinsufficiency is unlikely to be associated with Y-chromosome microdeletions. BACKGROUND Y-chromosome microdeletions are not commonly known as a major molecular genetic cause of any pathological condition except spermatogenic failure. However, it has been recently proposed that they are associated not only with infertility but also with anomalies in the pseudoautosomal regions (PAR), among which SHOX haploinsufficiency stands out with a frequency of 5.4% in microdeletion carriers bearing a normal karyotype. This finding implies that sons fathered by men with Y-chromosome defects will not only exhibit fertility problems, but might also suffer from SHOX-related conditions. METHODS Five European laboratories (Florence, Münster, Barcelona, Padova and Ancona), routinely performing Y-chromosome microdeletion screening, were enrolled in a multicenter study. METHODS PAR-linked and SHOX copy number variations (CNVs) were analyzed in 224 patients carrying Y-chromosome microdeletions and 112 controls with an intact Y chromosome, using customized X-chromosome-specific array-CGH platforms and/or qPCR assays for SHOX and SRY genes. RESULTS Our data show that 220 out of 224 (98.2%) microdeletion carriers had a normal SHOX copy number, as did all the controls. No SHOX deletions were found in any of the examined subjects (patients as well as controls), thus excluding an association with SHOX haploinsufficiency. SHOX duplications were detected in 1.78% of patients (n = 4), of whom two had an abnormal and two a normal karyotype. This might suggest that Y-chromosome microdeletions have a higher incidence for SHOX duplications, irrespective of the patient's karyotype. However, the only clinical condition observed in our four SHOX-duplicated patients was infertility. CONCLUSIONS The number of controls analyzed is rather low to assess whether the SHOX duplications found in the two men with Y-chromosome microdeletions and a normal karyotype represent a neutral polymorphism or are actually associated with the presence of the microdeletion. CONCLUSIONS Men suffering from infertility due to the presence of Y-chromosome microdeletions can resort to artificial reproductive technology (ART) to father their biological children. However, infertile couples must be aware of the risks implied and this makes genetic counseling a crucial step in the patient's management. This study does not confirm previous alarming data that showed an association between Y-chromosome microdeletions and SHOX haploinsufficiency. Our results imply that deletion carriers have no augmented risk of SHOX-related pathologies (short stature and skeletal anomalies) and indicate that there is no need for radical changes in genetic counseling of Yq microdeletion carriers attempting ART, since the only risk established so far for their male offspring remains impaired spermatogenesis. BACKGROUND This work was supported by the Italian Ministry of University (grant PRIN 2010-2012 to C.K.), Tuscan Regional Health Research Program ('Progetto Salute 2009') to G.F., the Spanish Ministry of Health (grant FIS-11/02254) and the European Union 'Reprotrain' Marie Curie Network (project number: 289880 to C.K.). The authors declare that no conflicting interests exist.

UI MeSH Term Description Entries
D007248 Infertility, Male The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility. Sterility, Male,Sub-Fertility, Male,Subfertility, Male,Male Infertility,Male Sterility,Male Sub-Fertility,Male Subfertility,Sub Fertility, Male
D008297 Male Males
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074122 Short Stature Homeobox Protein A homeodomain protein that is highly expressed in the nuclei of skeletal muscle, bone marrow, and osteogenic cells and has critical roles in growth and development. Its gene resides within PSEUDOAUTOSOMAL REGION 1 of X and Y chromosomes and mutations are associated with several growth disorders including LERI-WEIL SYNDROME; LANGER MESOMELIC DYSPLASIA; and SHORT STATURE, IDIOPATHIC, X-LINKED. GCFX Protein,PHOG Protein,SHOX Protein,SHOXY Protein
D017384 Sequence Deletion Deletion of sequences of nucleic acids from the genetic material of an individual. Deletion Mutation,Deletion Mutations,Deletion, Sequence,Deletions, Sequence,Mutation, Deletion,Mutations, Deletion,Sequence Deletions
D055028 Comparative Genomic Hybridization A method for comparing two sets of chromosomal DNA by analyzing differences in the copy number and location of specific sequences. It is used to look for large sequence changes such as deletions, duplications, amplifications, or translocations. Array Comparative Genomic Hybridization,Array-Based Comparative Genomic Hybridization,Comparative Genome Hybridization,Array Based Comparative Genomic Hybridization,Comparative Genome Hybridizations,Comparative Genomic Hybridizations,Genome Hybridization, Comparative,Genome Hybridizations, Comparative,Genomic Hybridization, Comparative,Genomic Hybridizations, Comparative,Hybridization, Comparative Genome,Hybridization, Comparative Genomic,Hybridizations, Comparative Genome,Hybridizations, Comparative Genomic
D057895 Haploinsufficiency A copy number variation that results in reduced GENE DOSAGE due to any loss-of-function mutation. The loss of heterozygosity is associated with abnormal phenotypes or diseased states because the remaining gene is insufficient. Haploinsufficiencies
D059785 Karyotype The full set of CHROMOSOMES presented as a systematized array of METAPHASE chromosomes from a photomicrograph of a single CELL NUCLEUS arranged in pairs in descending order of size and according to the position of the CENTROMERE. (From Stedman, 25th ed) Karyotypes
D018398 Homeodomain Proteins Proteins encoded by homeobox genes (GENES, HOMEOBOX) that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development (GENE EXPRESSION REGULATION, DEVELOPMENTAL). Homeo Domain Protein,Homeobox Protein,Homeobox Proteins,Homeodomain Protein,Homeoprotein,Homeoproteins,Homeotic Protein,Homeo Domain Proteins,Homeotic Proteins,Domain Protein, Homeo,Protein, Homeo Domain,Protein, Homeobox,Protein, Homeodomain,Protein, Homeotic,Proteins, Homeo Domain,Proteins, Homeobox,Proteins, Homeodomain,Proteins, Homeotic

Related Publications

C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
May 2014, Human reproduction (Oxford, England),
C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
November 2009, American journal of obstetrics and gynecology,
C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
December 2005, Human reproduction (Oxford, England),
C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
December 2010, Human reproduction (Oxford, England),
C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
May 2006, Nihon rinsho. Japanese journal of clinical medicine,
C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
January 2022, Cytogenetic and genome research,
C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
September 2003, Journal of pediatric endocrinology & metabolism : JPEM,
C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
December 1998, Contraception, fertilite, sexualite (1992),
C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
August 1997, Annals of medicine,
C Chianese, and D Lo Giacco, and F Tüttelmann, and A Ferlin, and P Ntostis, and S Vinci, and G Balercia, and E Ars, and E Ruiz-Castañé, and S Giglio, and G Forti, and S Kliesch, and C Krausz
January 1998, Human fertility (Cambridge, England),
Copied contents to your clipboard!